Lilly New Diabetes Drug - Search News

News

Eli Lilly Vows to Make Weight-Loss Pill in U.S.

UPI on MSN · 1d

Experimental Eli Lilly weight loss drug proves promising for type 2 diabetics

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its latest clinical testing, the Indianapolis-based drugmaker announced Thursday.

USA TODAY on MSN · 1d

Eli Lilly announces trial results of new weight loss, diabetes pill; stock booms

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial.

CBS News on MSN · 1d

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.

1d

Lilly Soars As Study Shows Weight-Loss Pill to Pass Ozempic

Eli Lilly & Co. shares surged after its experimental pill helped patients shed weight and control blood sugar about as well ...

4don MSN

Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results